Obesity and Pancreatic Cancer: Overview of Epidemiology and Potential Prevention by Weight Loss
- PMID: 29346216
- PMCID: PMC6018023
- DOI: 10.1097/MPA.0000000000000974
Obesity and Pancreatic Cancer: Overview of Epidemiology and Potential Prevention by Weight Loss
Abstract
Currently, there are no effective preventive strategies for pancreatic cancer. Obesity has been increasingly recognized as a strong but modifiable risk factor of pancreatic cancer. In this article, we aim to review the literature regarding weight loss on prevention of pancreatic cancer. Epidemiological and laboratory studies have shown that obesity is associated with increased incidence of pancreatic cancer and potentially worse cancer outcome. Whereas the underlying pathomechanisms remain unclear, chronic inflammation, insulin resistance, and altered intestinal microbiota are all implicated in the carcinogenic effect of obesity. Weight loss, especially the durable and significant weight loss after bariatric surgery, has been shown to reduce the risks of multiple cancers and may become a good intervention for pancreatic cancer prevention.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Tsai J, Ford ES, Zhao G, et al. Multiple health behaviors and serum hepatic enzymes among US adults with obesity. Prev Med. 2011;53:278–283. - PubMed
-
- Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev. 2002;11(Suppl 2):S94–S100. - PubMed
-
- Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454:436–444. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical